We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
1326
DELISTED
Acorda Therapeutics
ACOR
$12K ﹤0.01%
6
+1
+20% +$2.18K
CCXI
1327
DELISTED
ChemoCentryx, Inc.
CCXI
$12K ﹤0.01%
1,076
ALXN
1328
DELISTED
Alexion Pharmaceuticals
ALXN
$12K ﹤0.01%
+124
New +$14.7K
AAP icon
1329
Advance Auto Parts
AAP
$3.49B
$11K ﹤0.01%
70
-965
-93% -$161K
ACLS icon
1330
Axcelis
ACLS
$4.33B
$11K ﹤0.01%
637
-105
-14% -$1.87K
AL
1331
DELISTED
Air Lease Corp
AL
$11K ﹤0.01%
378
-23,147
-98% -$883K
BLFS icon
1332
BioLife Solutions
BLFS
$1.7B
$11K ﹤0.01%
891
+698
+362% +$8.34K
COKE icon
1333
Coca-Cola Consolidated
COKE
$12.8B
$11K ﹤0.01%
620
-250
-29% -$4.63K
EXPE icon
1334
CALL
Expedia Group
EXPE
$37.3B
$11K ﹤0.01%
100
-15,200
-99% -$1.82M
F icon
1335
CALL
Ford
F
$55.7B
$11K ﹤0.01%
+1,500
New +$13.4K
MMSI icon
1336
Merit Medical Systems
MMSI
$5.32B
$11K ﹤0.01%
+202
New +$12K
NSIT icon
1337
Insight Enterprises
NSIT
$4.38B
$11K ﹤0.01%
260
SEIC icon
1338
SEI Investments
SEIC
$12.6B
$11K ﹤0.01%
244
+121
+98% +$6.37K
UVV icon
1339
Universal Corp
UVV
$1.27B
$11K ﹤0.01%
205
-30
-13% -$1.93K
CVA
1340
DELISTED
Covanta Holding Corporation
CVA
$11K ﹤0.01%
+837
New +$12.9K
GSUM
1341
DELISTED
Gridsum Holding Inc.
GSUM
$11K ﹤0.01%
4,890
-22,069
-82% -$104K
CCMP
1342
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$11K ﹤0.01%
+112
New +$11K
CBPX
1343
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$11K ﹤0.01%
440
+80
+22% +$2.34K
AVP
1344
DELISTED
Avon Products, Inc.
AVP
$11K ﹤0.01%
7,011
+3,113
+80% +$5.96K
AEIS icon
1345
Advanced Energy
AEIS
$13B
$10K ﹤0.01%
242
+8
+3% +$356
OPTU
1346
CALL
Optimum Communications Inc
OPTU
$301M
$10K ﹤0.01%
+600
New +$10.4K
FIX icon
1347
Comfort Systems
FIX
$59.6B
$10K ﹤0.01%
224
-76
-25% -$3.89K
HALO icon
1348
Halozyme
HALO
$12.2B
$10K ﹤0.01%
708
HRB icon
1349
CALL
H&R Block
HRB
$5.86B
$10K ﹤0.01%
400
IIIN icon
1350
Insteel Industries
IIIN
$625M
$10K ﹤0.01%
427
+237
+125% +$6.58K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.